These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22685558)

  • 21. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
    Guttà C; Rahman A; Aura C; Dynoodt P; Charles EM; Hirschenhahn E; Joseph J; Wouters J; de Chaumont C; Rafferty M; Warren M; van den Oord JJ; Gallagher WM; Rehm M
    Cell Death Dis; 2020 Feb; 11(2):124. PubMed ID: 32054850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of galectin-3 in primary cutaneous melanoma.
    Buljan M; Šitum M; Tomas D; Milošević M; Krušlin B
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1174-81. PubMed ID: 21175876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
    O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
    BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
    Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
    Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multimarker prognostic assay for primary cutaneous melanoma.
    Kashani-Sabet M; Venna S; Nosrati M; Rangel J; Sucker A; Egberts F; Baehner FL; Simko J; Leong SP; Haqq C; Hauschild A; Schadendorf D; Miller JR; Sagebiel RW
    Clin Cancer Res; 2009 Nov; 15(22):6987-92. PubMed ID: 19887476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
    Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
    Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
    Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
    Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
    Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
    J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
    Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
    J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma prognostic model using tissue microarrays and genetic algorithms.
    Gould Rothberg BE; Berger AJ; Molinaro AM; Subtil A; Krauthammer MO; Camp RL; Bradley WR; Ariyan S; Kluger HM; Rimm DL
    J Clin Oncol; 2009 Dec; 27(34):5772-80. PubMed ID: 19884546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel role for RGS1 in melanoma progression.
    Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
    Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
    Bedin V; Adam RL; de Sá BC; Landman G; Metze K
    BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melastatin expression and prognosis in cutaneous malignant melanoma.
    Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ
    J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.